Enveda’s journey from a startup to $1 billion company in six years is fueled by investors betting big on its AI-led approach to drug discovery.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
Early-stage companies saw an increase in capital from 2021. Click here to view original post
WESTMINSTER, Colo., Oct. 11, 2022 /PRNewswire/ — Inovonics, an industry leader in wireless solutions for life-safety applications, announces the launch of two new next-generation solutions for the senior living market: fall detection and alarm location. […]
The company appears on the Inc. 5000 at #1147, with a three-year revenue growth of over 500% COLORADO SPRINGS, Colo., Aug. 16, 2022 /PRNewswire/ — Professional Transition Strategies (PTS), a company that represents dental practice […]
Copyright © 2026 Biotech Networks
